Literature DB >> 7308281

Pharmacokinetics and mechanism of renal excretion of short acting sulphonamides and N4-acetylsulphonamide derivatives in man. Structural requirements of sulphonamides for active tubular secretion.

T B Vree, Y A Hekster, J E Damsma, M Tijhuis, W T Friesen.   

Abstract

The pharmacokinetics of short acting sulphonamides and a series of N4-acetylsulphonamide derivatives has been investigated. Sulphonamides with a sulphur atom two atomic bond distances from the N1 atom are excreted by active tubular secretion, e.g. sulphamethizole, sulphaethidole and sulphathiasole. When the sulphur atom is replaced by an oxygen or nitrogen atom, active renal excretion no longer occurs. N4-acetylsulphonamides are excreted by active tubular secretion. The renal clearance values of the N4-acetylsulphonamides are not influenced by the substituent at the N1 position. Two groups of N4-acetylsulphonamides can be distinguished. One has a T1/2 of 4-6 h and a renal clearance value of 20-60 ml/min and the second has a T1/2 of 10-20 h and a renal clearance of less than 10 ml/min. N4-acetylsulphonamides are deacetylated to the extent of about 5%.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7308281     DOI: 10.1007/bf00618779

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  12 in total

1.  Factors basic to the development of useful inhibitors of renal transport mechanisms.

Authors:  K H BEYER
Journal:  Arch Int Pharmacodyn Ther       Date:  1954-05-01

2.  Acetylation and deacetylation of the p-amino group of sulphonamide drugs in animal tissues.

Authors:  H A Krebs; W O Sykes; W C Bartley
Journal:  Biochem J       Date:  1947       Impact factor: 3.857

3.  Renal tubular secretion of sulfonamides and p-aminobenzoic acid.

Authors:  F LUNDQUIST
Journal:  Acta Pharmacol Toxicol (Copenh)       Date:  1945

Review 4.  Progress in sulfonamide research.

Authors:  T Struller
Journal:  Prog Drug Res       Date:  1968

5.  Metabolism of procainamide in rhesus monkey and man.

Authors:  J Dreyfuss; J T Bigger; A I Cohen; E C Schreiber
Journal:  Clin Pharmacol Ther       Date:  1972 May-Jun       Impact factor: 6.875

6.  Pharmacokinetics of N1-acetyl- and N4-acetylsulphamethoxazole in man.

Authors:  T B Vree; Y A Hekster; J E Damsma; E van der Kleijn; W J O'Reilly
Journal:  Clin Pharmacokinet       Date:  1979 Jul-Aug       Impact factor: 6.447

Review 7.  Sulfonamides, structure-activity relationship, and mode of action. Structural problems of the antibacterial action of 4-aminobenzoic acid (PABA) antagonists.

Authors:  J K Seydel
Journal:  J Pharm Sci       Date:  1968-09       Impact factor: 3.534

8.  Multiple N-acetyltransferases and drug metabolism. Tissue distribution, characterization and significance of mammalian N-acetyltransferase.

Authors:  D J Hearse; W W Weber
Journal:  Biochem J       Date:  1973-03       Impact factor: 3.857

9.  Renal excretion of sulphamethoxazole and its metabolite N4-acetylsulphamethoxazole in patients with impaired kidney function.

Authors:  T B Vree; Y A Hekster; J E Damsma; R van Dalen; J C Hafkenscheid; W T Friesen
Journal:  Ther Drug Monit       Date:  1981       Impact factor: 3.681

10.  Determination of the acetylator phenotype and pharmacokinetics of some sulphonamides in man.

Authors:  T B Vree; W J O'Reilly; Y A Hekster; J E Damsma; E van der Kleijn
Journal:  Clin Pharmacokinet       Date:  1980 May-Jun       Impact factor: 6.447

View more
  5 in total

1.  Effect of intra-articular glucocorticoids on the disposition of sulphadimidine in chronic osteoarthritis patients.

Authors:  P T Reeves; P Hanrahan; J Edelman; K F Ilett
Journal:  Br J Clin Pharmacol       Date:  1988-11       Impact factor: 4.335

Review 2.  Pharmacokinetic considerations in rational drug design.

Authors:  M Gumbleton; W Sneader
Journal:  Clin Pharmacokinet       Date:  1994-03       Impact factor: 6.447

3.  Effects of methoxy groups in the NI-substituent of sulfonamides on the pathways of elimination in man. The acetylation-deacetylation equilibrium and mechanisms of renal excretion of sulfisomidine, sulfamethomidine and sulfadimethoxine.

Authors:  T B Vree; Y A Hekster; M W Tijhuis; M Baakman; M J Oosterbaan; E F Termond
Journal:  Pharm Weekbl Sci       Date:  1984-08-24

4.  Isolation and identification of 4-hydroxysulfamerazine and preliminary studies on its pharmacokinetics in dogs.

Authors:  T B Vree; M W Tijhuis; J F Nouws; Y A Hekster
Journal:  Pharm Weekbl Sci       Date:  1984-04-27

5.  The effect of the molecular structure of closely related N1-substituents of sulfonamides on the pathways of elimination in man. The acetylation-deacetylation equilibrium and renal clearance related to the structure of sulfadiazine, sulfamerazine and sulfadimidine.

Authors:  T B Vree; Y A Hekster; M W Tijhuis; M Baakman; T J Janssen; E F Termond
Journal:  Pharm Weekbl Sci       Date:  1983-04-29
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.